Tier and alert level are a summary. Unlock DRUG to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.
−5.41%▼, downReturn · 1w
+10.54%▲, upReturn · 1m
−8.67%▼, downReturn · 3m
+90.62%▲, upReturn · 1y
−35.77%, well below its 52-week highvs 52-week high
Technicals
Technical readings
The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.
The same report, read from different investor horizons: what each would count for its case, and what each would count against it.
Full analysis
What unlocking DRUG reveals
Short term · weeks—Mid term · months—Long term · business quality—
These classifications are computed from live data. The detail behind them is what unlocks.
Sample preview: figures are illustrative.
Company & theme write-up
Sample
Business write-up(full description)
Theme write-up(how it fits)
Themes tagged3
Profile factsincluded
What the company actually does is described in full, with a second write-up on the themes it belongs to and the theme tags that place it beside its peers.
Signal history
Sample
Signal episodes measured12
Median 3-month move+6.4%
Positive after 3 months8 of 12
Signal types covered3
Every past volume signal is measured forward from the day it fired: how many episodes there were, and where price stood one and three months later.
AI narrative
Sample
Narrative sections5
Key drivers(analysis locked)
Evidence per claim(analysis locked)
The AI narrative ties the volume, technical and fundamental reads into one plain-language story, with each flagged risk paired to its figure.
Catalysts & risks
Sample
Earnings date(dated, with countdown)
Risks flagged3
Risk evidence(paired to figures)
Catalysts read(analysis locked)
Scheduled calendar events are set beside the risks the narrative flags, each risk paired to the figure behind it where one exists.
Accumulation read
Sample
Accumulation percentile87th
Relative volume (5d)2.4×
Volume z-score (3d)+3.1
Money flow (CMF 20)+0.18
Float turnover0.7%
Volume has run above its recent median for several sessions while price held its range, a pattern the full read breaks down day by day.
WatchVolume signalVolume signal tier C, alert level baseline.
WatchGrowth & qualityunlock to view
WatchValuationunlock to view
CautionTop risk flaggedunlock to view
The setup
Fundamental readings are mixed; mid-term technical readings are rangebound (RSI 54). Neither horizon shows a decisive read. Short-term momentum is flat.
The full analysis breaks down the specific fundamental and risk factors behind this setup.
Short term · weeksMomentum flatMid term · monthsRangeboundLong term · business qualityMixedMarket linkloosely tracksthe S&P 500
These classifications are computed from DRUG's live data. The detail behind them is what unlocks.
Sample preview: figures are illustrative.
Company & theme write-up
Sample
Business write-up(full description)
Theme write-up(how it fits)
Themes tagged3
Profile factsincluded
What the company actually does is described in full, with a second write-up on the themes it belongs to and the theme tags that place it beside its peers.
Signal history
Sample
Signal episodes measured12
Median 3-month move+6.4%
Positive after 3 months8 of 12
Signal types covered3
Every past volume signal is measured forward from the day it fired: how many episodes there were, and where price stood one and three months later.
Signals & levels
Sample
Computed signals1 buy · 1 sell
Price bands studied6
Sessions in current band37
Median 1-month move after+3.8%
Signals computed from this stock's own price bands; each names the sessions it was measured over and the move that followed, descriptive of the past.
AI narrative
Sample
Narrative sections5
Key drivers(analysis locked)
Evidence per claim(analysis locked)
The AI narrative ties the volume, technical and fundamental reads into one plain-language story, with each flagged risk paired to its figure.
Catalysts & risks
Sample
Earnings date(dated, with countdown)
Risks flagged3
Risk evidence(paired to figures)
Catalysts read(analysis locked)
Scheduled calendar events are set beside the risks the narrative flags, each risk paired to the figure behind it where one exists.
Social sentiment
Sample
Overall toneMixed
Attributed voices6
Catalysts cited4
Strongest points3 + 3
Attributed voices from public X posts, the catalysts they cite and the strongest points on each side, quoted, linked and tone-tagged in the full section.
Fundamentals & valuation
Sample
Revenue (TTM)$94.6B
Net income (TTM)$21.4B
Free cash flow$18.2B
EBITDA (TTM)$27.9B
Enterprise value$412.0B
Margins and cash generation lead the vote table here, with growth metrics splitting the read; the full table shows every input.
Market context & correlations
Sample
S&P 500r 0.62 · stable
Technology sector ETF (XLK)r 0.71 · stable
VIX volatility indexr −0.48 · shifted
US 10-year Treasury yieldr 0.14
Beta1.18
Correlations against the index, sector fund and rates place the stock in its market neighborhood; the full table names each instrument and window.
Accumulation read
Sample
Accumulation percentile87th
Relative volume (5d)2.4×
Volume z-score (3d)+3.1
Money flow (CMF 20)+0.18
Float turnover0.7%
Volume has run above its recent median for several sessions while price held its range, a pattern the full read breaks down day by day.